Table 5.
Multiple linear regression model for a relative increase of fluorescent product growth velocity (R factor) in the real-time CBA assay in asthma patients. Presented variables were documented as independent determinants; they explain 33% of R factor variability.
| Fluorescent Product Growth Velocity (R Factor) | ||
|---|---|---|
| β (95% CI) | R2 | |
| Monocyte count, 103/μL | 0.14 (0.02 to 0.28) | 0.33 |
| Red blood cell count, 106/μL | −0.58 (−0.73 to −0.43) | |
| Blood eosinophilia, 103/μL | −0.23 (−0.41 to −0.06) | |
| Citrulinated histone 3, ng/mL | 0.22 (0.07 to 0.37) | |
| Interleukin 17A, pg/mL | 0.26 (0.13 to 0.4) | |
| Total cholesterol, mmol/L | 0.22 (0.08 to 0.37) | |
| Adjustment statistics | F = 3.3, p = 0.01 | |
For data interpretation, see footnote to Table 3.